. 2019 May 19;25:3700–3715. doi: 10.12659/MSM.914162

Table 6.

Relationship between the expression of FTH1 and clinicopathological parameters in KIRP.

Clinicopathological parameters		n	Relevant expression of FTH1 (log₂X)
Clinicopathological parameters		n	Mean ±SD	t	p Value
Age (years)	<60	121	15.1689±0.80649	−2.036^a	0.043^*
Age (years)	≥60	169	15.3572±0.75462	−2.036^a	0.043^*
Gender	Male	214	15.2485±0.73904	−1.104^a	0.270
Gender	Female	76	15.3636±0.88799	−1.104^a	0.270
Lymph node metastasis	Yes	55	15.5165±0.71347	−2.595^a	0.010^*
Lymph node metastasis	No	231	15.2159±0.78573	−2.595^a	0.010^*
Stage	I–II	193	15.2106±0.74507	−2.963^a	0.003^*
Stage	III–IV	67	15.5353±0.84850	−2.963^a	0.003^*
T	T1–T2	226	15.1841±0.74460	−3.763^a	0.000^*
T	T3–T4	64	15.6124±0.81967	−3.763^a	0.000^*
Pathologic stage	I	172	15.1891±0.73811	F=3.326^b	0.019^*
	II	21	15.3870±0.79651
	III	52	15.5188±0.82226
	IV	15	15.5928±0.96255
Pathologic T	T1	193	15.1791±0.73574	F=5.591^b	0.010^*
	T2	33	15.2134±0.80731
	T3	60	15.5878±0.78798
	T4	4	15.9815±1.30530
M	No	95	15.1953±0.73192	−1.429^a	0.154
M	Yes	180	15.3378±0.82060	−1.429^a	0.154

SD – standard deviation.

A Student’s paired or unpaired t test was used for comparison between two group;

One-way analysis of variance (ANOVA) was performed.

p<0.05 was considered statistically significant.